X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Journal of Ophthalmology

期刊標題檢索 INT J OPHTHALMO 最新評論: Can I check if you accept it in the end? (2023-08-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Journal of Ophthalmology]您好,您是該頁面的第 26397 位訪客。

期刊簡介
期刊名稱International Journal of Ophthalmology International Journal of Ophthalmology
LetPub Score
5.9
50 ratings
Rate

Reputation
7.1

Influence
4.8

Speed
7.1

期刊簡稱INT J OPHTHALMOL-CHI
ISSN2222-3959
E-ISSN2227-4898
h-index18
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.500.5210.637
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q265 / 137

自引率 (2023-2024)26.30%自引率趨勢
掲載範囲
· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication
and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).
This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from
WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,
PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.

IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific
Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);
Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,
Chinese Academy of Engineering.
International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of
blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of
AAO/PAAO) et al.
Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of
Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and
Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).
Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).
Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).
Associate Editors-in-Chief include:
Prof. Ning-Li Wang (President Elect of APAO);
Prof. Ke Yao (President of Chinese Ophthalmological Society) ;
Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;
Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);
Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);
Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);
Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).

IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,
both basic and clinical papers.
Instruction is Welcome Contribution is Welcome Citation is Welcome

Cooperation organization

International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
官方網站http://www.scimagojr.com/journalsearch.php?q=130135&tip=sid
在線稿件提交
開放訪問Yes
出版商Press of International Journal of Ophthalmology
主題領域OPHTHALMOLOGY
出版國/地區PEOPLES R CHINA
發行頻率
創刊年2008
每年文章數262每年文章數趨勢
黃金OA百分比99.74%
OA Related Info
APC: Yes( USD1800; )
APC waiver:No
Other charges: No
Keywords: ophthalmology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ244/95
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2222-3959%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【International Journal of Ophthalmology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640941
    BIOMATERIALS573191
    BIOMEDICINE & PHARMACOTHERAPY498364
    Frontiers in Pharmacology487240
    JOURNAL OF ETHNOPHARMACOLOGY479235
    Journal of Materials Chemistry B476064
    Frontiers in Immunology458015
    COLLOIDS AND SURFACES B-BIOINTERFACES419241
    COMPUTERS IN BIOLOGY AND MEDICINE416582
    Frontiers in Oncology413495
  •  

    International Journal of Ophthalmology International Journal of Ophthalmology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [International Journal of Ophthalmology] 的評論撰寫評論
作者: 魔都凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-28 20:31:23 評論於
Can I check if you accept it in the end?
(0) 讚! | 魔都凝芙

作者: 日光怜雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-18 19:57:00 評論於
Review Speed: 12.0 | Submission Hit Rate: 75.0
Experience Sharing: The review speed is too slow
(0) 讚! | 日光怜雁

作者: 晨风欢悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-24 12:07:13 評論於
Review speed: 12.0 | Submission success rate: 75.0
Experience sharing: The review process is very slow, but the success rate is relatively high. I am preparing to submit again next time
(0) 讚! | 晨风欢悦

作者: 龙爪宜修


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-09 08:35:33 評論於
Would you mind accepting the delivery in the end?
(0) 讚! | 龙爪宜修

作者: 龙爪宜修


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-30 12:37:37 評論於
Have you received your acceptance? I have been awaiting reviewer selection. Should I follow up, and how are reviewers usually selected?
(0) 讚! | 龙爪宜修

作者: 文耀来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-07 17:41:59 評論於
Research focus: Ophthalmology. Sharing of ophthalmology experiences: After submitting for over six months, the status has always been Awaiting AE Recommendation. What could be the issue? Feeling uncertain. The manuscript has already undergone minor revisions. Can anyone provide guidance?
(0) 讚! | 文耀来了

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:51:10 評論於
Please translate the following paragraph into English and Japanese
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:42:14 評論於
The title of the paper should be concise and not too long. In order to accurately reflect and clearly express the most important specific content, fewer words are better, and unnecessary words should be avoided as much as possible. Shorter paper titles generally have a higher citation rate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:12:45 評論於
How many words are generally required for an article title?
(0) 讚! | 魂魄彦露

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:10:30 評論於
What to Do When Article Titles Are Too Long?
(0) 讚! | 平原文波

作者: 一吃就胖小明熙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-03 21:11:50 評論於
It has been over three months since submission, and the status still shows "Awaiting Reviewer Assignment." Is this normal?
(0) 讚! | 一吃就胖小明熙

作者: 月河小星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-12 18:50:03 評論於
Review speed: 3.0 | Submission acceptance rate: 95.0
Research focus: Ophthalmology
Experience sharing: It took 4 months from submission to acceptance. The journal editors are Chinese so communication was excellent. The only downside is the expensive page charges of 2000rmb/page. Hopefully, the page charges can be more favorable to Chinese researchers
(0) 讚! | 月河小星

作者: 北国天路


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-21 17:35:03 評論於
Review speed: 24.0 | Submission acceptance rate: 50.0
Sharing experience: It took more than a year from submission to acceptance, and even longer to publication. Feeling dizzy
(0) 讚! | 北国天路

作者: 北国天路


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-03 21:08:34 評論於
Review speed: 24.0 | Submission acceptance rate: 50.0
Shared experience: This journal is too quirky. I've asked multiple times, it's been over a year, and still no conclusion
(0) 讚! | 北国天路

作者: 通幽寄菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-08-14 18:46:32 評論於
It has been a total of one year and three months from submission to now, going through two major revisions and one minor revision, only to be rejected in the end, citing insufficient research background. I am not sure if I can appeal
(0) 讚! | 通幽寄菡

作者: 北国天路


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-08-11 21:09:48 評論於
It took so long for minor revisions, it looks like major revisions will be even slower
(0) 讚! | 北国天路

作者: 法慧婉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-19 11:20:46 評論於
Finally received after 7 and a half months, will be published in August. The two articles written during this period have been published. Keep up the good work~
(0) 讚! | 法慧婉容

作者: 法慧婉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-30 19:40:24 評論於
After several reminders, the first review results finally came back. After making major revisions, I hope to get the results soon.
RoseTiger 2019-04-17 00:00:00 posted: Is it a garbage magazine that doesn't allow evaluations? Several comments have not been released. I don't want to criticize you, but isn't it too much that even after six months the first review hasn't come out? You might have to go to heaven. If you're writing articles for college applications, don't submit them to this magazine. Otherwise, you won't even know how you died. Be careful where you submit!
(0) 讚! | 法慧婉容

作者: 稻妻明知


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-28 20:17:58 評論於
Review Speed: 3.0
Experience Sharing: I submitted it in October last year. Today, in March, I received a minor revision request and still haven't received the results. The journal is generally slow, so be cautious when submitting urgent articles
(0) 讚! | 稻妻明知

作者: 法慧婉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-17 17:47:41 評論於
Review Speed: 12.0 | Submission Hit Rate: 25.0
Experience Sharing: Is the rubbish magazine not allowing reviews? Several comments couldn't come out, and I don't want to criticize you either. But you're really too much. The first review hasn't come out in six months? You might as well go to heaven. If you want to use articles for academic advancement, don't submit to this magazine. Otherwise, you won't even know how you died. Be cautious about submitting!
(0) 讚! | 法慧婉容

作者: 法慧婉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-08 16:01:42 評論於
Review speed: 6.0 Experience sharing: I am very helpless about this magazine. It has been over four months since I submitted the manuscript and the review has not been completed yet. Hurry up for graduation, it's really annoying... Be careful when submitting, don't make the same mistake. Completely deceived by the official website's review cycle
(0) 讚! | 法慧婉容

作者: Kelly Hutt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-15 08:48:50 評論於
Is this funny?
(0) 讚! | Kelly Hutt

作者: Iris Curme


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-18 09:44:18 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted in early December, received external review comments in mid-January, accepted in early April, the speed is still acceptable; page fees are around 10,000 RMB
(0) 讚! | Iris Curme

作者: 家馨大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-29 22:52:47 評論於
The feeling is quite good. It takes about two months for review, and it is also quite accurate and detailed
(0) 讚! | 家馨大叔

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 09:21:08 評論於
Cross the one-point threshold, may the gods bless! Let's aim for over 2 points next year
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [International Journal of Ophthalmology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*